November 2012 Issue Table Of Contents

From The Editor

• Warning: Navigating Economic Uncertainty In Life Sciences

Ask The Board

• Ask The Board November 2012

Companies To Watch

• Aeras: A Pandemic Need Produces A Nonprofit Player

Outsourcing Insights

• When It Comes To Outsourcing Relationships, Essential Qualities Vary

Big Data Points

• Single-Use Recycling Mismatch: BioPharmaceutical Manufacturers Missing An Opportunity

Feature

• Eli Lilly And Company – Open For Innovation
• The Rx For Dx Leadership At Roche

Inside The Industry

• Biopharms Embrace Companion Diagnostics To Advance Personalized Medicine & Address Drug Costs Concerns
• How To Mitigate Pharma Supply Chain Risks
• mHealth Could Cut Clinical Trial Time And Money In Half
• Smart Sourcing At the Outset
• The 5 Steps Of Contingency Planning

Industry Leader

• Accelerating Drug Development By Harnessing Technology
• Quantifying The Potential Value Of Orphan Drugs
• Urgency: Leadership’s Strategy Accelerator